Nasdaq

Nasdaq
Share

Nasdaq

 •  January 8

BioScrip, Inc., the largest independent national provider of infusion and home care management solutions, today announced that it can now dispense and administer HEMLIBRA® (emicizumab-kxwh), a U.S. Food and Drug Administration (FDA) approved treatment for routine...

Nasdaq

 •  November 27, 2017

(RTTNews.com) - The American Depositary Receipts of Indivior plc (INVVY.OB), a global specialty pharmaceutical company focused on developing opioid dependence treatments, are up nearly 38% year-to-date. After getting thumbs up from an FDA panel for RBP-6000, its investigational treatment for opioid use disorder, Indivior now awaits the regulatory...

Nasdaq

 •  October 9, 2017

Shares of Teleflex IncorporatedTFX rallied to a new 52-week high of $248.68 on Oct 6, closing a tad lower at $246.05. This represents a strong return of approximately 16.4% over the last three months, better than the S&P 500's 5.1% over the same time frame. Teleflex designs, develops, manufactures, and supplies single-use medical devices for common...

Nasdaq

 •  October 5, 2017

DENVER, Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, is pleased to announce that it can now dispense and administer Radicava® (edaravone), the first treatment option for amyotrophic lateral sclerosis (ALS)...

Nasdaq

 •  October 3, 2017

Boston Scientific Corporation BSX recently announced plans to acquire Campbell, CA-based privately-held company Apama Medical Inc. for a total value of around $300 million. This is in line with the company's strategy to gain traction in the Electrophysiology market, which is poised to reach a value of more than $9 billion in 2017 (as per data by...

Nasdaq

 •  September 14, 2017

Low rates of major PICC-associated complications attributed in-part to the novel BioFlo catheter material Data to be presented at AngioDynamics-sponsored symposium at the annual scientific meeting of the Association for Vascular Access ALBANY, N.Y., Sept. 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative,...

Nasdaq

 •  August 17, 2017

SAN CLEMENTE, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will participate at the 15th Annual Global Healthcare Conference in New...

Nasdaq

 •  July 26, 2017

Legislation Accelerates Medicare Payment of Home Infusion Therapy Services to 2019 DENVER, July 26, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the US House of Representatives passed HR 3178, the...

Nasdaq

 •  July 10, 2017

Spark Therapeutics Presents Updated Interim Hemophilia B Data Supporting Consistent and Sustained Response at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress Data demonstrate a 99-percent reduction in annualized infusion rate (AIR) and a 96-percent reduction in annualized bleeding rate (ABR) in 10 participants as of...

Nasdaq

 •  July 3, 2017

Pfizer Inc. PFE announced that its leukemia candidate, Besponsa, has been approved by the European Commission. The drug is approved as a monotherapy for relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL), including patients with either Philadelphia chromosome positive (Ph+) or Philadelphia chromosome negative...